Using the Chinese Smell Identification Test to explore olfactory function in Parkinson's disease.

Area of Science:

• Neurology
• Otolaryngology
• Medical Diagnostics

Background:

• Olfactory dysfunction is a prevalent non-motor symptom in Parkinson's disease (PD).
• The Chinese Smell Identification Test (CSIT) was developed for Chinese populations to assess olfactory deficits.
• There is ongoing debate regarding the efficacy of pharmacological interventions for anosmia in PD patients.

Purpose of the Study:

• To evaluate the olfactory function in Chinese individuals with Parkinson's disease.
• To ascertain the diagnostic utility of the CSIT for Parkinson's disease detection.
• To investigate the impact of dopaminergic medications on olfactory dysfunction in PD.

Main Methods:

• 149 Parkinson's disease patients and 149 healthy comparison participants (HCP) were recruited.
• Olfactory function was assessed using the Chinese Smell Identification Test (CSIT) for all participants.
• Statistical analyses included t-tests and Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

• PD patients exhibited significantly lower CSIT scores compared to HCP (t(296) = -12.797, P < 0.001).
• The CSIT demonstrated a sensitivity of 71.1% and specificity of 89.3% for PD detection with an optimal threshold of 22.5.
• Male participants were more prone to olfactory dysfunction (t = -3.552, P = 0.001).
• PD patients on medication showed improved CSIT scores compared to those not on medication (t(41) = -3.067, P < 0.0167).

Conclusions:

• The CSIT is a valuable tool for enhancing the sensitivity of Parkinson's disease detection in China.
• Olfactory function in Parkinson's disease patients can be improved through treatment with dopaminergic drugs.